U.S. Specialty Stores Stock News

If you are wondering whether BJ's Wholesale Club Holdings is priced attractively or already reflects its strengths, it helps to start with how the current share price lines up against different valuation checks. The stock closed at US$92.24, with returns of a 1.5% decline over 7 days, a 4.4% decline over 30 days, a small 0.3% gain year to date, and a 22.1% decline over the last year, following a 19.0% return over 3 years and 112.9% over 5 years. Recent coverage has focused on BJ's position...

If you are wondering whether Domino's Pizza is starting to look attractively priced, this article explains what the current share price might be implying about its value. The stock last closed at US$369.00, with a 1.2% decline over 7 days, a 6.9% decline over 30 days, a 13.2% decline year to date and a 19.6% decline over 1 year. The 3 year return stands at 19.4% and the 5 year return at a 1.2% decline. Recent coverage has focused on how the share price performance contrasts with earlier...

In recent days, Barclays highlighted DoorDash’s early partnerships with sidewalk robots and delivery drones as part of a broader industry shift toward autonomous last‑mile logistics that could cut delivery costs to around US$1 per order. This focus on automation, alongside DoorDash’s public alignment with US “no tax on tips” policies that have saved Dashers hundreds of millions of dollars, underscores how technology and regulation are jointly reshaping its cost base and worker...

Leadership change puts BioCryst’s R&D focus in the spotlight BioCryst Pharmaceuticals (BCRX) recently named Sandeep M. Menon as Chief Research and Development Officer, putting fresh attention on how new leadership could shape the company’s rare disease pipeline and longer term growth plans. See our latest analysis for BioCryst Pharmaceuticals. The appointment of Dr. Menon comes at a time when BioCryst’s share price has a 90 day share price return of 42.9% and a 1 year total shareholder return...

Q1 beat on revenue and profits despite softer egg prices Cal-Maine Foods (CALM) reported Q1 revenue and profit above analyst expectations, a key development for shareholders given the pressure from lower egg prices and questions about the durability of recent earnings. See our latest analysis for Cal-Maine Foods. At a share price of $76.31, Cal-Maine Foods has seen a 1 day share price return of 1.72%, while its 1 month share price return of 11.90% decline contrasts with a 5 year total...

With Yum China Holdings up 19.9% over the past year, many investors are asking a simple question: is the current share price of US$48.54 offering good value, or is most of the upside already reflected? The picture is mixed in the shorter term, with a 3.2% decline over the last 7 days and a 10.1% decline over the last 30 days, while year to date the stock is roughly flat at a 0.8% gain. It is still ahead over 3 years, and lower over 5 years, with returns of 19.1% and 11.5% declines...

CRA International (CRAI) is back in focus after recent share price swings. The stock has been roughly flat over the past year but has shown a negative move over the past 3 months. See our latest analysis for CRA International. Recent trading tells a mixed story, with a 4.1% 30 day share price return set against a 23.1% decline over 90 days, while the 5 year total shareholder return of 126.2% reflects much stronger long term performance. If CRA International’s recent swings have you thinking...

Spire (NYSE:SR) agreed to sell its natural gas storage assets in Wyoming and Oklahoma to I Squared Capital. The transaction shifts Spire's portfolio toward regulated natural gas utilities and supports funding for its recent Nashville acquisition. The move reflects a material change in business mix and risk profile that has not yet been widely discussed. Spire is primarily a regulated natural gas utility, and this agreement to sell Wyoming and Oklahoma storage assets tightens that focus. By...

If you are wondering whether Brunswick at around US$77 per share still offers value, you are not alone, especially after the stock's strong run over the past year. The share price is at US$77.33, with a 7 day return of a 0.8% decline, 30 day return of 8.0%, year to date return of 1.9% and 1 year return of 81.2%, while the 3 year and 5 year returns sit at a 3.3% decline and a 16.8% decline. Recent moves in the stock have drawn more attention to how the market is currently pricing Brunswick...

Earlier this week, Gilead Sciences announced expanded collaborations with the U.S. State Department, PEPFAR, and The Global Fund to widen access to its twice-yearly injectable HIV prevention medicine, lenacapavir, targeting up to an additional 1 million people through 2028 in high-incidence, resource-limited regions. This move not only extends Gilead’s reach in global HIV prevention but also highlights how no-profit pricing and planned generic rollout could reshape its role in public health...

Over the last 7 days, the United States market has experienced a significant decline of 29%, contributing to an overall drop of 82% over the past year, though earnings are forecast to grow by 16% annually. In such volatile conditions, identifying stocks that are undervalued relative to their intrinsic value can present opportunities for investors seeking potential long-term gains.

In recent days, CoreWeave completed and expanded multiple private offerings of its 9.750% senior notes due 2031, raising an additional US$1.00 billion at a price of 102% on top of an earlier US$1.75 billion tranche, while also issuing US$3.50 billion of 1.75% convertible notes due 2032. Alongside these financings, new multi-year AI cloud agreements with Meta Platforms, Anthropic and a roughly US$6.00 billion commitment from Jane Street, plus Jane Street’s US$1.00 billion equity purchase, are...

If you are wondering whether Gap's share price still offers value after a strong run, or if most of the opportunity is already priced in, this article breaks down what the current market price might be implying about the company. Gap's stock has seen a 40.3% return over the last year and 209.3% over the last 3 years, while the most recent 7 day return of a 1.1% decline sits against a 9.4% gain over the last 30 days and a 3.5% return year to date. Recent headlines around Gap have focused on...

Western Midstream Partners triggered stock overview Western Midstream Partners (WES) has drawn fresh attention after recent trading, with the units closing at US$40.85. Investors are weighing this level against the partnership’s income profile and longer term return record. See our latest analysis for Western Midstream Partners. The latest move to US$40.85 comes after a modest 1 day share price return of 1.09%, set against a slightly weaker 30 day share price return of 1.47%. At the same...

Over the last 7 days, the United States market has experienced a significant drop of 29%, contributing to an overall decline of 82% over the past year. In light of these challenging conditions, identifying growth companies with substantial insider ownership can be particularly appealing as it often indicates confidence in future performance and alignment with shareholder interests.

Over the last 7 days, the United States market has experienced a significant downturn, dropping 29%, and is down 82% over the past year, though earnings are forecast to grow by 16% annually. In challenging market conditions like these, identifying stocks with strong financial fundamentals becomes crucial for investors seeking potential opportunities. Although "penny stocks" may seem like an outdated term, they continue to represent smaller or newer companies that can offer both affordability...

If you are wondering whether Fluor's current share price lines up with its underlying worth, this breakdown will help you connect the recent share performance with what the fundamentals may be implying. The stock recently closed at US$47.88, with returns of 7.2% over 30 days, 14.8% year to date and 41.0% over 1 year. This puts valuation questions front and center for many investors. Over longer periods, Fluor has recorded returns of 60.0% over 3 years and 122.9% over 5 years. This provides...

Earlier this month, Annexon, Inc. presented at the 25th Annual Needham Virtual Healthcare Conference, where CEO Douglas E. Love outlined the company’s upcoming clinical and regulatory milestones. A key takeaway was management’s description of 2026 as a “win year,” highlighting expected GBS regulatory filings, a Phase III geographic atrophy readout, and proof-of-concept data for ANX1502, all supported by a cash runway projected into the second half of 2027. We’ll now look at how this “win...

Over the last 7 days, the United States market has experienced a significant drop of 29%, and over the past year, it has declined by 82%, though earnings are expected to grow by 16% per annum in the coming years. In this challenging environment, identifying stocks with strong fundamentals and growth potential can be key to uncovering hidden gems that may offer promising opportunities.

In early April 2026, Gold.com, Inc. increased its remaining equity buyback authorization to 2,000,000 shares and scheduled a May 6, 2026 conference call to discuss fiscal third-quarter results ended March 31, 2026. This combination of a larger repurchase plan and an imminent earnings discussion highlights management’s emphasis on capital return and transparency around performance and strategy. Against this backdrop, we’ll explore how the expanded share buyback program may influence...

What Recent Returns Say About Boston Beer Company (SAM) Boston Beer Company (SAM) has drawn attention after a mix of short term and longer term share performance, with the stock showing small daily moves alongside a month of gains and a weaker past 3 months. For investors tracking the name, the shares show a month return of about 6% but a past 3 months gain closer to 18%, while the 1 year total return sits near 2%. Longer horizons look different, with the 3 year total return around a 24%...

This article examines whether JetBlue Airways, trading at around US$5.51, is a bargain or a value trap by exploring what the current price implies about the stock. The share price has moved sharply in the short term, with returns of 11.8% over 7 days, 30.9% over 30 days, 20.0% year to date and 50.1% over 1 year. However, the 3 year and 5 year returns of negative 18.7% and negative 72.2% present a very different longer term picture. Recent headlines around JetBlue have focused on its position...

MPLX (NYSE:MPLX) has secured a new multi year, multi billion dollar revolving credit agreement totaling $2.5 billion. The facility replaces prior credit lines and is designed to support future partnership activities and liquidity needs. Sponsor Marathon Petroleum has also renewed its own multi year revolving credit agreement with a broad banking group. MPLX enters this refinancing with units trading at $55.24 and a 1 year return of 18.2%. Over 3 years, the return is 104.8%, and over 5 years...

Lam Research (NasdaqGS:LRCX) is being approached as a core equipment supplier for Elon Musk's Terafab project, a multi company US semiconductor manufacturing initiative targeting 2029. Terafab involves companies such as Tesla, SpaceX, Intel, and xAI, with an ambition to build a large scale facility focused on advanced 2nm chip production. The project aims to bring more of the semiconductor production chain onshore in the US, potentially reshaping supplier relationships across the...